Claim market intelligence specific for the stem cell sector. Learn profitable opportunities that you can pursue. Discover trends, metrics, and industry data that separate the key players in the stem cell marketplace from the rest of the competition.
Because we believe all customers should be repeat customers, all BioInformant products are backed by a progressive 60-Day Money Back Guarantee. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.
The cord blood industry has matured substantially, creating both serious threats and new opportunities. Threats include accreditation requirements that have increased cost structures, a decline in cord blood transplants, low rates of turnover for stored cord blood, expensive transplant procedures, and difficulty educating obstetricians about cellular therapy.
Other uncontrollable factors that could threaten the industry include: continually evolving accreditation requirements, the potential for competitive approaches to be shown more optimal, shifts in policy recommendations, changes in transplant reimbursement, new laws, and more. Marketing pressures also exist, as the term “cord blood” is one of the 20 most expensive search terms on Google, reaching more than $30 per click.
However, there are also emerging opportunities, including new clinical trial data supporting applications for cord blood, improving public perception toward stem cell therapies, deal-making within the industry, and more. As these factors vary somewhat by market, there is an advantage to having a global understanding. The report contains metrics for cord blood clinical trials, patents, publications, and grants, as well as survey findings from 600+ parents who reveal fears, expectations, and perceptions about cord blood banking.
Cord blood banks, as well as investors, will benefit from these recently released 2015-16 market metrics.
Since the discovery of induced pluripotent stem cells in 2006, a large and thriving research product market has grown into existence. The number of induced pluripotent stem cell products sold worldwide is currently growing at an annual rate of 14.7%. In addition, 22% of all stem cell researchers now self-report having used iPSCs within a research project.
It is clear that iPSCs represent a lucrative product market for companies to pursue, and this report is your guide to claiming maximal profits from the sector.
A distinctive feature of this industry report is a survey of 274 iPSC researchers (131 U.S. / 143 International) that reveals end-user needs, technical preferences, factors influencing purchasing decisions, and more. Claim these insider insights to improve your product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.
Staying ahead in a rapidly-evolving marketplace requires the very best market insights. Whether you already supply stem cell research products or you are planning to enter the market, you know how important it is to make informed, educated decisions. You need to launch high-demand products, sell effectively to scientists, increase revenue, and take market share from your competition.
This overview report shows you how to do just that - providing global strategies for the stem cell industry and identifying unique market opportunities by stem cell type (iPSC, MSC, NSC, ESC, and more). It contains metrics and trend rate data to help you to understand prevailing market conditions and guide you to strategically position your stem cell products. It also includes a Scientist Survey that reveals the technical requirements, unmet needs, and purchasing preferences among stem cell researchers worldwide.
With the possibility of treating and curing chronic neurological diseases such as Parkinson’s and Alzheimer's, the interest in neuronal stem and progenitor cells has become profound in the research community. This means huge opportunities for your stem cell product company.
This market intelligence report gives you detailed guidance to strategically develop and position neural stem cell (NSC) products.
Claim the report to understand advances in NSC research, explore the competitive environment for NSC product development, examine 5-year market growth projections, view trends in NSC grants, patents, and publications, and much more.
With a 60-day money-back guarantee and the opportunity to understand and profit from the NSC product market, you should read more.
Put simply, this report will help you understand and profit from the Mesenchymal stem cell (MSC) market – the fastest growing area of stem cell research.
Updated to reflect the most current trends and including a five year market projection, this report focuses on the advances in MSC research. In 126 pages you’ll explore research priorities by market segment, highlight individual labs and end-users of MSC products, understand the competitive environment for such products and discover market-leading trend analysis.
If you’re looking to supply stem cell products to this rapidly growing and well-funded market, then this is the report for you. Buy today to get our 60-day money-back guarantee.
Because human embryonic stem cells (hESCs) are the most pluripotent of all stem cells, they have been proposed for use in a range of applications, including toxicology testing, tissue engineering, cellular therapies, and more.
However, hESC research is heavily encumbered by patents held by the University of Wisconsin's Alumni Research Foundation (WARF), which creates significant challenges for companies seeking to develop new products. This 158-page market intelligence report provides guidance for navigating the complex IP landscape and gives you a wealth of valuable market data to ensure you effectively develop hESC products and technologies.
A distinctive feature of this report is a survey of 247 hESC researchers (101 U.S. / 146 International) that reveal research needs, technical preferences, and factors influencing purchasing decisions. This report too comes with a 60-day, no questions asked, money-back guarantee.
In this revealing 2014 survey, 117 human embryonic stem cell (hESC) and human induced pluripotent stem cell (hiPSC) researchers reveal how and why they make decisions about stem cell culture products. Specifically, you will learn the key forces influencing purchasing behaviors, brand preferences, and factors influencing use of feeder-dependent vs. feeder-free culture. Remember, you need to serve the needs of your clients, or your competitors will.
BioInformant also produces custom research for stem cell companies. We work within your budget and timeline and guarantee that you will receive market insights that will lead to strategic dominance.
For custom projects, we structure them as a defined project scope and fee. First, we discuss your needs. Next, we offer you 3 Tier Levels to choose from that vary in scope and price. Finally, you choose what combination best meets your needs. To learn more, inquire via live chat or call us at 703.859.7617.